Promising early study results released today by clinical stage drug development company Pharmaxis (ASX: PXS), should be a reason for…
The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter…
Leading fund manager Karst Peak Capital has secured a significant interest in a little-known Aussie pharmaceuticals research company, following the…
In biotech circles, tackling a rare and difficult disease with few patients does not necessarily equate to targeting an unprofitable…
One of the world’s most respected surgeons in the field of burns and trauma recovery will lead world-first clinical trials…